Yang Liu

First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study

Xiaofeng Chen, Hao Xu, Xiaobing Chen et al. · Signal Transduction and Targeted Therapy · 2024 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Effects of berbamine against myocardial ischemia/reperfusion injury: Activation of the 5' adenosine<scp>monophosphate‐activated</scp>protein kinase/nuclear factor erythroid<scp>2‐related</scp>factor pathway and changes in the mitochondrial state

Chennian Xu, Yang Liu, Mengen Zhai et al. · BioFactors · 2022 · 16 citations · Full text

Medicine, Cardiology, Pharmacology +15

Transcatheter Closure of Mitral Paravalvular Leak via Multiple Approaches

Yang Liu, Chennian Xu, Peng Ding et al. · Journal of Interventional Cardiology · 2021 · 13 citations · Full text

Medicine, Cardiology, Surgery +16

Vitamin D Inhibits colorectal cancer cell proliferation, migration and invasion via downregulating the Notch1 pathway

Yang Liu, Xiangcai Meng, Xin Zhang et al. · Cellular and Molecular Biology · 2023 · 10 citations · Full text

Medicine, Oncology, Pharmacology +12